Jannine responds to paracetamol study

Jannine responds to paracetamol study

Jannine responds to study claiming paracetamol ‘not clinically effective’ in treating osteoarthritis

We’re urging consumers and our members to be cautious and stay informed about their medication following a study published today that claimed paracetamol is ‘not clinically effective’ in treating pain or improving physical function in patients with knee and hip osteoarthritis.

Our CEO, Jannine Jackson, speaks to many of our 5,000 active members on a regular basis, some of whom have osteoarthritis. Their feedback about the medication’s effectiveness has been mixed, with some claiming it works and others saying they don’t notice a reduction in pain.

“Osteo-paracetamol is one of those medications which work for quite a number of people, especially those with osteoarthritis,” Jannine said. “It doesn’t work for everybody, but it’s medication that’s safe and often takes enough of the pain away so that people can function and take part in life.

“As an organisation, we don’t recommend drugs as the sole method of treatment for arthritis. There is strong evidence supporting diet and exercise as effective strategies for managing osteoarthritis and pain. Even losing small amounts of weight can have a significant benefit.

“There was a fairly big study done with people who had knee osteoarthritis and it found that those who lost 5kg of excess weight experienced a 50 percent reduction in their knee pain,” Jannine said. “For every small amount of weight loss you achieve, you’re actually multiplying that benefit on the affected joints.”

Before making any changes to medication, consumers should seek medical advice.

If you are interested in learning more about managing your osteoarthritis, please visit our Take Charge of Osteoarthritis page or call our Help & Support Line on 1800 011 041.

Click on the image below to watch a conversation we had with Jannine about this recent study.

Jannine responds to paracetamol study

Ends

The study was published today in the journal The Lancet.